FCPM III SERVICES B.V.
Q1 2025 13F Holdings
- Locationnaarden, P7
- Num holdings
7
- Value ($000)
$413,711
- Date Filed05/15/2025
- Form type13F-HR
- CIK0002013410
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | $223.85M | 54 % | 10,935,310 | ||
DYN DYNE THERAPEUTICS INC | COM | 26818M108 | $57.14M | 14 % | 5,462,846 | ||
ENGN ENGENE HOLDINGS INC | COM | 29286M105 | $43.15M | 10 % | 9,632,561 | ||
REPL REPLIMUNE GROUP INC | COM | 76029N106 | $38.12M | 9 % | 3,909,696 | ||
BCYC BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | $29.31M | 7 % | 3,452,330 | ||
ATXS ASTRIA THERAPEUTICS INC | COM | 04635X102 | $20.41M | 5 % | 3,822,537 | ||
ENGNW ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | $1.73M | 0 % | 2,878,148 |
Rows Per Page
10
- 10
- 50
- 100